K. Matsuda, Y. Tanaka; S. Ushiyama; K. Ohnishi; M. Yamazaki, Inhibition of prostaglandin synthesis by sodium 2-[4-(2-oxocyclopentylmethyl)phenyl] propionate dihydrate (CS-600), a new anti-inflammatory drug, and its active metabolite in vitro and in vivo., in Biochem Pharmacol, vol. 33, n. 15, Aug 1984, pp. 2473-8, PMID 6431982.
Y. Tanaka, Y. Nishikawa; R. Hayashi, Species differences in metabolism of sodium 2-[4-(2-oxocyclopentylmethyl)-phenyl]propionate dihydrate (loxoprofen sodium), a new anti-inflammatory agent., in Chem Pharm Bull (Tokyo), vol. 31, n. 10, Oct 1983, pp. 3656-64, PMID 6671226.
Y. Tanaka, Y. Nishikawa; K. Matsuda; M. Yamazaki; R. Hayashi, Purification and some properties of ketone reductase forming an active metabolite of sodium 2-[4-(2-oxocyclopentylmethyl)-phenyl]propionate dihydrate (loxoprofen sodium), a new anti-inflammatory agent, in rabbit liver cytosol., in Chem Pharm Bull (Tokyo), vol. 32, n. 3, Mar 1984, pp. 1040-8, PMID 6744478.
N. Yamakawa, S. Suemasu; A. Kimoto; Y. Arai; T. Ishihara; K. Yokomizo; Y. Okamoto; M. Otsuka; K. Tanaka; T. Mizushima, Low direct cytotoxicity of loxoprofen on gastric mucosal cells., in Biol Pharm Bull, vol. 33, n. 3, 2010, pp. 398-403, PMID 20190399.
A. Yanagawa, T. Fukumura; H. Matsui; H. Uemura; T. Endo; T. Nakagawa; Y. Mizushima, Possible mechanisms of gastroduodenal mucosal damage in volunteers treated with nonsteroidal antiinflammatory drugs--the usefulness of prodrugs., in J Rheumatol, vol. 19, n. 7, Jul 1992, pp. 1075-82, PMID 1512761.
M. Sugimoto, T. Kojima; M. Asami; Y. Iizuka; K. Matsuda, Inhibition of prostaglandin production in the inflammatory tissue by loxoprofen-Na, an anti-inflammatory prodrug., in Biochem Pharmacol, vol. 42, n. 12, Nov 1991, pp. 2363-8, PMID 1764120.
S. Naruto, Y. Tanaka; R. Hayashi; A. Terada, Structural determination of rat urinary metabolites of sodium 2-[4-(2-oxocyclopentylmethyl)phenyl]propionate dihydrate (loxoprofen sodium), a new anti-inflammatory agent., in Chem Pharm Bull (Tokyo), vol. 32, n. 1, Jan 1984, pp. 258-67, PMID 6722952.
T. Araki, T. Yokoyama; H. Kumon, Effectiveness of a nonsteroidal anti-inflammatory drug for nocturia on patients with benign prostatic hyperplasia: a prospective non-randomized study of loxoprofen sodium 60 mg once daily before sleeping., in Acta Med Okayama, vol. 58, n. 1, Feb 2004, pp. 45-9, PMID 15157011.
T. Araki, T. Yokoyama; M. Araki; S. Furuya, A clinical investigation of the mechanism of loxoprofen, a non-steroidal anti-inflammatory drug, for patients with nocturia., in Acta Med Okayama, vol. 62, n. 6, Dec 2008, pp. 373-8, PMID 19122682.
T. Ii, Y. Doutsu; J. Ashitani; H. Taniguchi; M. Mizuta; H. Toshimori; S. Matsukura, [A case of loxoprofen-induced pulmonary eosinophilia]., in Nihon Kyobu Shikkan Gakkai Zasshi, vol. 30, n. 5, maggio 1992, pp. 926-9, PMID 1630061.
M. Tohyama, Y. Tamaki; M. Toyama; T. Ishimine; A. Miyazato; A. Nakamoto; T. Miyara; F. Higa; M. Tateyama; K. Kawakami; H. Nakamura, [A case of loxoprofen-induced pneumonitis pathologically resembling hypersensitivity pneumonitis]., in Nihon Kokyuki Gakkai Zasshi, vol. 40, n. 2, Feb 2002, pp. 123-8, PMID 11974866.
D. Tsuruta, T. Oshimo; J. Sowa; M. Ishii; H. Kobayashi, Unilateral eyelid angioedema with congestion of the right bulbar conjunctiva due to loxoprofen sodium., in Cutis, vol. 87, n. 1, Jan 2011, pp. 41-3, PMID 21323100.
Y. Uwai, R. Taniguchi; H. Motohashi; H. Saito; M. Okuda; K. Inui, Methotrexate-loxoprofen interaction: involvement of human organic anion transporters hOAT1 and hOAT3., in Drug Metab Pharmacokinet, vol. 19, n. 5, Oct 2004, pp. 369-74, PMID 15548848.